A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study
Top Cited Papers
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 79 (2) , 147-153
- https://doi.org/10.1006/gyno.2000.6001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1991
- Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1989
- A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1985
- Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicinVersus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group)Cancer, 1985
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983
- Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamideGynecologic Oncology, 1983
- Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tractGynecologic Oncology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952